Vernalis plc, of Winnersh, U.K., and Suresnes, France-based Les Laboratoires Servier SAS achieved a new milestone in their first oncology drug discovery collaboration, triggering a payment of €500,000 (US$550,750) to Vernalis related to success against an undisclosed target.